Data Foundry

Drug recalls 2026

Thyroid Tablets — Class I drug recall D-0866-2026

Ongoing recall by VITRUVIAS THERAPEUTICS INC, reported 2026-09-23, distributed nationwide. Superpotent Drug

Recall numberD-0866-2026
Product typeDrug
ClassificationClass I
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmVITRUVIAS THERAPEUTICS INC, Auburn, AL, United States
Recall initiated2026-08-21
Classified2026-09-22
Reported by FDA2026-09-23
DistributedNationwide (US)
Quantity1,955 bottles
Reason classespotency
NDC69680-0165, 69680-0165-00, 69680-0166, 69680-0166-00, 69680-0167, 69680-0167-00, 69680-0168, 69680-0168-00, 69680-0169, 69680-0169-00
Lot numbers504950
Expiration dates2026-09-30

Product

Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.

Reason for recall

Superpotent Drug

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0866-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-29. Not affiliated with or endorsed by FDA. Not medical or legal advice.